Cargando…

Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches

316In recent years, extrusion-based three-dimensional (3D) bioprinting is employed for engineering cardiac patches (CP) due to its ability to assemble complex structures from hydrogel-based bioinks. However, the cell viability in such CPs is low due to shear forces applied on the cells in the bioink...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Assaf, Kryukov, Olga, Etzion, Sharon, Cohen, Smadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090809/
https://www.ncbi.nlm.nih.gov/pubmed/37065655
http://dx.doi.org/10.18063/ijb.v9i2.670
_version_ 1785023038441390080
author Bar, Assaf
Kryukov, Olga
Etzion, Sharon
Cohen, Smadar
author_facet Bar, Assaf
Kryukov, Olga
Etzion, Sharon
Cohen, Smadar
author_sort Bar, Assaf
collection PubMed
description 316In recent years, extrusion-based three-dimensional (3D) bioprinting is employed for engineering cardiac patches (CP) due to its ability to assemble complex structures from hydrogel-based bioinks. However, the cell viability in such CPs is low due to shear forces applied on the cells in the bioink, inducing cellular apoptosis. Herein, we investigated whether the incorporation of extracellular vesicles (EVs) in the bioink, engineered to continually deliver the cell survival factor miR-199a-3p would increase the viability within the CP. EVs from THP-1-derived activated macrophages (MΦ) were isolated and characterized by nanoparticle tracking analysis (NTA), cryogenic electron microscopy (cryo-TEM), and Western blot analysis. MiR-199a-3p mimic was loaded into EVs by electroporation after optimization of applied voltage and pulses. Functionality of the engineered EVs was assessed in neonatal rat cardiomyocyte (NRCM) monolayers using immunostaining for the proliferation markers ki67 and Aurora B kinase. To examine the effect of engineered EVs on 3D-bioprinted CP viability, the EVs were added to the bioink, consisting of alginate-RGD, gelatin, and NRCM. Metabolic activity and expression levels of activated-caspase 3 for apoptosis of the 3D-bioprinted CP were evaluated after 5 days. Electroporation (850 V with 5 pulses) was found to be optimal for miR loading; miR-199a-3p levels in EVs increased fivefold compared to simple incubation, with a loading efficiency of 21.0%. EV size and integrity were maintained under these conditions. Cellular uptake of engineered EVs by NRCM was validated, as 58% of cTnT(+) cells internalized EVs after 24 h. The engineered EVs induced CM proliferation, increasing the ratio of cell-cycle re-entry of cTnT(+) cells by 30% (Ki67) and midbodies+ cell ratio by twofold (Aurora B) compared with the controls. The inclusion of engineered EVs in bioink yielded CP with threefold greater cell viability compared to bioink with no EVs. The prolonged effect of EVs was evident as the CP exhibited elevated metabolic activities after 5 days, with less apoptotic cells compared to CP with no EVs. The addition of miR-199a-3p–loaded EVs to the bioink improved the viability of 3D-printed CP and is expected to contribute to their integration in vivo.
format Online
Article
Text
id pubmed-10090809
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Whioce Publishing Pte. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100908092023-04-13 Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches Bar, Assaf Kryukov, Olga Etzion, Sharon Cohen, Smadar Int J Bioprint Research Article 316In recent years, extrusion-based three-dimensional (3D) bioprinting is employed for engineering cardiac patches (CP) due to its ability to assemble complex structures from hydrogel-based bioinks. However, the cell viability in such CPs is low due to shear forces applied on the cells in the bioink, inducing cellular apoptosis. Herein, we investigated whether the incorporation of extracellular vesicles (EVs) in the bioink, engineered to continually deliver the cell survival factor miR-199a-3p would increase the viability within the CP. EVs from THP-1-derived activated macrophages (MΦ) were isolated and characterized by nanoparticle tracking analysis (NTA), cryogenic electron microscopy (cryo-TEM), and Western blot analysis. MiR-199a-3p mimic was loaded into EVs by electroporation after optimization of applied voltage and pulses. Functionality of the engineered EVs was assessed in neonatal rat cardiomyocyte (NRCM) monolayers using immunostaining for the proliferation markers ki67 and Aurora B kinase. To examine the effect of engineered EVs on 3D-bioprinted CP viability, the EVs were added to the bioink, consisting of alginate-RGD, gelatin, and NRCM. Metabolic activity and expression levels of activated-caspase 3 for apoptosis of the 3D-bioprinted CP were evaluated after 5 days. Electroporation (850 V with 5 pulses) was found to be optimal for miR loading; miR-199a-3p levels in EVs increased fivefold compared to simple incubation, with a loading efficiency of 21.0%. EV size and integrity were maintained under these conditions. Cellular uptake of engineered EVs by NRCM was validated, as 58% of cTnT(+) cells internalized EVs after 24 h. The engineered EVs induced CM proliferation, increasing the ratio of cell-cycle re-entry of cTnT(+) cells by 30% (Ki67) and midbodies+ cell ratio by twofold (Aurora B) compared with the controls. The inclusion of engineered EVs in bioink yielded CP with threefold greater cell viability compared to bioink with no EVs. The prolonged effect of EVs was evident as the CP exhibited elevated metabolic activities after 5 days, with less apoptotic cells compared to CP with no EVs. The addition of miR-199a-3p–loaded EVs to the bioink improved the viability of 3D-printed CP and is expected to contribute to their integration in vivo. Whioce Publishing Pte. Ltd. 2023-01-17 /pmc/articles/PMC10090809/ /pubmed/37065655 http://dx.doi.org/10.18063/ijb.v9i2.670 Text en Copyright: © 2023, Bar A, Kryukov O, Etzion S, https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, permitting distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bar, Assaf
Kryukov, Olga
Etzion, Sharon
Cohen, Smadar
Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title_full Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title_fullStr Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title_full_unstemmed Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title_short Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches
title_sort engineered extracellular vesicle-mediated delivery of mir-199a-3p increases the viability of 3d-printed cardiac patches
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090809/
https://www.ncbi.nlm.nih.gov/pubmed/37065655
http://dx.doi.org/10.18063/ijb.v9i2.670
work_keys_str_mv AT barassaf engineeredextracellularvesiclemediateddeliveryofmir199a3pincreasestheviabilityof3dprintedcardiacpatches
AT kryukovolga engineeredextracellularvesiclemediateddeliveryofmir199a3pincreasestheviabilityof3dprintedcardiacpatches
AT etzionsharon engineeredextracellularvesiclemediateddeliveryofmir199a3pincreasestheviabilityof3dprintedcardiacpatches
AT cohensmadar engineeredextracellularvesiclemediateddeliveryofmir199a3pincreasestheviabilityof3dprintedcardiacpatches